← All forecasts · November 2–6

ACLS / FQ3 2026 (quarter ended 2026-09-30)

Axcelis Technologies, Inc.

Reported: Nov 5, 2026

Forecast published

Opus 5.5 High in Shortcut

Review incomplete

Shortcut

1.15

Normalized diluted EPS

+3.4% vs Street

Off by $0.11 per share

Street

1.11

Normalized diluted EPS

November 1 consensus snapshot

Off by $0.15 per share

Real

1.26

Reported normalized EPS

Shortcut win

Reported result · Nov 5 ↗ · Provider normalized EPS 1.26 matches issuer non-GAAP diluted EPS 1.26.

USD per diluted ordinary/common share. Comparisons use unrounded estimates.

Model download

Explore the assumptions and calculations behind the forecast. This is the agent’s original workbook. Its review didn’t finish, so it hasn’t been checked or repaired.

Shortcut’s reasoning.

Issuer guided 3Q26 to ~$230m revenue, ~$1.11 non-GAAP EPS, 43% non-GAAP GM, ~$62m non-GAAP opex, ~15% tax (2026-08-06); frozen consensus ($1.11 / $230.08m, 5 estimates) equals guidance.

Axcelis beat its own non-GAAP EPS guidance midpoint in all 5 quarters since it began guiding non-GAAP (avg +$0.23, min +$0.01) and revenue guidance in 6 of 6 (avg +$11m); the model takes only a modest step: revenue $234.4m (+$4.4m) from 33.2% backlog conversion of $451.6m systems backlog plus $84.5m CS&I.

Margins held at guidance (43.0% non-GAAP GM; 2Q26 GM missed by 30bp on CS&I mix/service costs), opex $62.5m (variable comp on higher revenue), non-GAAP tax 14.5% vs ~15% guide (realized 13.7-14.2% in normal quarters), 31.2m diluted shares (no buybacks while Veeco merger pending) → $1.148.

Quarter evidence is supportive but not decisive: Lam (China 35% of sales, mature-node China spend), KLA and ASML beat in the September quarter; China SME imports turned positive y/y in Aug-2026; the Oct-30 ACLS -10.7% move was a sector-wide selloff, and the Oct-27 CFO appointment is non-operational.

P(beat) = size-aware start 0.829 (mid-cap $3.1bn, not S&P 500; 6/6 historical beats; (8×0.70+6)/14) less 0.05 for consensus sitting exactly on guidance, the 2Q26 gross-margin miss and lumpy memory timing → 0.779.

On the record.

Reporting period
FQ3 2026 (quarter ended 2026-09-30)
Reporting basis
Non-GAAP (normalized EPS) diluted EPS, USD per diluted common share; excludes Veeco transaction & integration costs, restructuring, bad debt and stock-based compensation, net of tax at the issuer's 14% adjusted rate
Consensus snapshot
November 1, 2026
Model / effort
Opus 5.5 · High effort
Workbook
Original workbook · review incomplete
Record history
Forecast generated
Nov 1, 2026 at 10:10 PM PST
First posted
Nov 2, 2026 at 4:10 PM PST
Result checked
Nov 6, 2026 at 1:55 AM PST
Result basis

Provider normalized EPS 1.26 matches issuer non-GAAP diluted EPS 1.26. All six frozen normalized historical EPS values match.